Skip to content

CDR

AmerisourceBergen names new board member

The board of AmerisourceBergen Corp. has elected Lon Greenberg as a new director. Greenberg, 62, fills the board vacancy that arose with the retirement of Charles Cotros in February, AmerisourceBergen said Thursday.

Tavenner confirmed as CMS administrator

The Senate has confirmed Marilyn Tavenner as administrator of the Centers for Medicare & Medicaid Services (CMS). Marilyn Tavenner Tavenner, who was nominated to the post in February by President Barack Obama, was confirmed by the Senate Wednesday in a 91-7 vote.

Mylan releases Zomig generic

Mylan Inc. has received final approval from the Food and Drug Administration for zolmitriptan tablets, a treatment for migraine headaches. The company said Wednesday that its zolmitriptan product, which has begun shipping, comes in dosages of 2.

Depend unveils light bladder leakage solution for men

Kimberly-Clark has launched Depend Guards and Shields, two new products for men with light bladder leakage. The incontinence product brand said Wednesday that Depend Guards and Shields are designed to fit a man’s body and can be worn securely in a man’s own underwear.

Poll: Women can save more on beauty purchases

By making greater use of coupons and discount codes and purchasing store-brand items, women could save more on beauty care purchases at chain drug and mass retailers, according to a survey from Consumer Reports.

Gender, race impact adherence, CVS-led study shows

CVS Caremark-led research found that among those using statin drugs for cardiovascular disease, nonwhite patients were 50% more likely not to adhere to their medication than white patients, and women were 10% more likely to be nonadherent than men.

Hillary Clinton to speak at Total Store Expo

Former Secretary of State Hillary Rodham Clinton is slated to deliver an address at the NACDS Total Store Expo in August. Hillary Rodham Clinton The National Association of Chain Drug Stores said Monday that Clinton will speak during the expo’s Business Program on the morning of Monday, Aug. 12.

Ranbaxy to pay $500 million in DOJ settlement

India-based Ranbaxy Laboratories Ltd. has agreed to pay a total of $500 million in what the U.S. Department of Justice (DOJ) called the largest drug safety settlement to date with a generic drug manufacturer. The DOJ said Monday that Ranbaxy USA Inc., the company’s U.S.